Abstract
Nuclear nanomedicine forms a new research field based on the synergy of nuclear medicine and nanotechnology and implying the use of nanomaterials as carriers of diagnostic or therapeutic radionuclides. Such an approach promises a series of advantages over classical methods of nuclear medicine, including an increased surface area-to-volume ratio, passive/active delivery, high loading capacity, large cross-section in interactions with biological tissues, and unique properties of nanomaterials that make possible many functionalities within one construct. In this short review article, we will highlight our recent achievements in the development of nuclear nanomedicine technologies, which promise the advancement of methods for cancer treatment.
Export citation and abstract BibTeX RIS
Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.